Drugs / ANTI-ANGIN® FORMULA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT03095521 Comparator | Feb → May 2017 | pharyngitis | Sandoz | Completed | Met primary |
| Phase 3 | NCT03095508 Comparator | Feb → May 2017 | pharyngitis | Sandoz | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ANTIANGIN FORMULA | “ANTIANGIN ® FORMULA, 1 lozenge, with an interval 2 hours or more, up to 6 lozenges per day, for a maximum 5 days or until full illness resolution, if this will happen earlier...” NCT03095521 ↗ |
| Route | Topical | “ANTI-ANGIN® FORMULA, topical metered spray” NCT03095508 ↗ |